Blonder Tongue Laboratories, Inc. BDRLQ
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 14.99% | 4.61% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.99% | 4.61% | -- | -- | -- |
| Cost of Revenue | 27.85% | 8.56% | -- | -- | -- |
| Gross Profit | -6.74% | -4.17% | -- | -- | -- |
| SG&A Expenses | -6.57% | -14.12% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 391.44% | -- | -- | -- |
| Total Operating Expenses | 1.75% | 9.58% | -- | -- | -- |
| Operating Income | 48.56% | -30.24% | -- | -- | -- |
| Income Before Tax | -3,050.51% | -182.84% | -- | -- | -- |
| Income Tax Expenses | -- | 0.00% | -- | -- | -- |
| Earnings from Continuing Operations | -3,577.38% | -180.88% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3,577.38% | -180.88% | -- | -- | -- |
| EBIT | 48.56% | -30.24% | -- | -- | -- |
| EBITDA | 47.25% | -37.18% | -- | -- | -- |
| EPS Basic | -2,105.45% | -99.14% | -- | -- | -- |
| Normalized Basic EPS | 20.43% | -48.38% | -- | -- | -- |
| EPS Diluted | -527.17% | -74.25% | -- | -- | -- |
| Normalized Diluted EPS | 19.69% | -49.67% | -- | -- | -- |
| Average Basic Shares Outstanding | 9.31% | 13.78% | -- | -- | -- |
| Average Diluted Shares Outstanding | 2.42% | 6.25% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |